Advances in genomics and combinatorial chemistry during the past two decades inspired innovative technologies and changes in the discovery and pre-clinical development paradigm with the goal of accelerating the process of bringing therapeutic drugs to market. Written by William Kisaalita, one of the foremost experts in this field, 3D Cell-Based Bio

part |2 pages

PART I Introduction

chapter 1|20 pages

Biosensors and Bioassays

chapter 2|32 pages

Target-Driven Drug Discovery

part |2 pages

PART II 3D versus 2D Cultures

part |2 pages

PART III Emerging Design Principles

part |2 pages

Part IV. Technology Deployment Challenges and Opportunities

chapter 12|18 pages

Cases for 3D Cultures in Drug Discovery

chapter 13|16 pages

Ideal Case Study Design